Search results
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) possesses the right combination of the two key ingredients for a likely earnings beat...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 2 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
WKRN Nashville· 1 day agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter 2024 financial ...
Novavax’s top shareholder Shah Capital ramps up efforts for board shakeup
WSAU Wausau· 2 days ago(Reuters) - Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Shah Capital seeks board overhaul at Novavax By Investing.com
Investing.com· 2 days agoShah Capital Management, a major shareholder in Novavax Inc. (NASDAQ:NVAX), has publicly expressed...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 31 minutes ago“The key reason for the withdrawal is likely to be that other Covid vaccines, such as Pfizer and Moderna, are essentially better products. AstraZeneca is...
Novavax, Inc. (NASDAQ:NVAX) Shares Sold by Federated Hermes Inc.
ETF DAILY NEWS· 2 days agoFederated Hermes Inc. lowered its position in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 88.6% in the fourth quarter, according to the company in its most recent ...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 2 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Novavax investor Shah Capital to vote against three directors
Reuters via Yahoo Finance· 2 days agoMay 6 (Reuters) - Hedge fund Shah Capital said on Monday that it intends to vote against election of three directors on the board of COVID-19 vaccine maker Novavax. Shah Capital ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
